uxawazebryauxwewdbceae

New & Noteworthy

Jun 20, 2017
Gregg Fisher reflects on how brand planning can be enhanced to better serve brand and product managers to deliver on the promises of “customer-centric” and “multi-channel” communications.
Jun 15, 2017
Bob Swindell explains how Greater Fort Lauderdale has spent the past few years quietly assembling one of the most dynamic pharmaceutical clusters in the country.
Jun 12, 2017
Pharmaceutical Executive
With the patient voice growing louder in all aspects of the drug development and commercialization journey, Pharm Exec examines some of the current industry thinking on the evolving pharma-patient relationship.
Jun 12, 2017
Pharmaceutical Executive
An honoree at HBA’s recent Women of the Year awards luncheon, Bahija Jallal’s story is one of courage and resilience.
Jun 11, 2017
Jackie DeAngelis outlines three common mistakes that hinder access attainment when launching a new drug.
Jun 10, 2017
Pharma has long recognized the power of key opinion leaders, but with HCPs and patients now acquiring much of their information online, there is a new opportunity for "digital opinion influencers".
Jun 09, 2017
As digital technologies transform drug development and marketing, a retooled medical affairs function can be a competitive differentiator, write Loic Plantevin, Christoph Schlegel and Maria Gordian.
Jun 08, 2017
Pharmaceutical Executive
Pharma leaders go on the defensive over drug pricing regulations, while experts slam the politicization of healthcare, writes Pharm Exec's Michelle Maskaly.
Jun 08, 2017
Pharmaceutical Executive
By Pharmaceutical Executive Editors
In its 11th annual feature, Pharm Exec breaks from the norm to instead profile five products that are currently shining the spotlight on critical and highly debated aspects of healthcare and R&D.
Jun 06, 2017
At recent the BETHEEXPERT 2017 event in Budapest, we asked Romuald Braun what pharma should be focusing on with regard to its labeling activities.
lorem ipsum